Navigation Links
Valeant Pharmaceuticals Reports 2011 First Quarter Financial Results
Date:5/9/2011

MISSISSAUGA, Ontario, May 9, 2011 /PRNewswire/ --

  • 2011 First Quarter Total Revenue $565 million, including $36 million related to out-license of Cloderm
  • Pro forma organic growth for the combined company, excluding the impact of foreign exchange and acquisitions, was approximately 7%
  • Excluding impact from Diastat and Efudex, pro forma organic growth for the combined company was approximately 11%
  • 2011 First Quarter GAAP EPS $0.02; Cash EPS $0.62
  • Excluding impact from Cloderm out-licensing, Cash EPS was $0.56
  • 2011 First Quarter GAAP Cash Flow from Operations was $86 million; Adjusted Cash Flow from Operations was $204 million  
  • 2011 Guidance increased to $2.65 - $2.90 Cash EPS

  • Valeant Pharmaceuticals International, Inc. (NYSE: VRX) (TSX: VRX) announces first quarter financial results for 2011.

    "Our performance in the first quarter is a strong start to what I believe will be another successful year for Valeant," said J. Michael Pearson, chairman and chief executive officer.  "Our specialty businesses performed well and our branded generic operations, in particular Central Europe, exceeded our expectations this quarter.  This strong performance is a testament to our diversified business model that gives us the ability to pursue acquisition opportunities, while continuing to deliver strong operating results."

    RevenueTotal revenue was $565.0 million in the first quarter of 2011 as compared to $219.6 million in the first quarter of 2010.  Included in total revenue was $36.0 million of alliance and royalty revenue related to the out-license of product rights for Cloderm, a mid-potency steroid with an annual revenue run rate of approximately $7 million, that was completed on March 31, 2011.  Product sales were $500.4 million in the fi
    '/>"/>

    SOURCE Valeant Pharmaceuticals International, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

    Related medicine technology :

    1. Valeant to Acquire Polish Products
    2. GSK and Valeant Announce New U.S. FDA PDUFA Goal Date for Ezogabine
    3. Valeant and Biovail Announce Results of Special Meetings of Shareholders
    4. Valeant Pharmaceuticals Announces Redemption and Defeasance of 7.625% Senior Notes Due 2020 and 8.375% Senior Notes Due 2016
    5. Valeant Pharmaceuticals Announces That Alexza Pharmaceuticals Has Received a Complete Response Letter for AZ-004 (Staccato® Loxapine) Inhalation Aerosol NDA
    6. Valeant Pharmaceuticals Reports 2010 Third Quarter Financial Results
    7. Valeant Declares Special Dividend and Plans to Create a Special Dividend Reinvestment Plan
    8. Valeant Announces Pricing of Senior Notes
    9. Valeant Pharmaceuticals Announces Appointment of Robert A. Ingram and Resignation of William M. Wells as Chairman
    10. Valeant Pharmaceuticals Appoints Philip W. Loberg as Interim CFO
    11. Regulatory Update - GSK and Valeant Receive Positive Opinion in Europe From the CHMP for Trobalt (Retigabine)
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:1/15/2014)... , Jan. 15, 2014 The Cadence Fitness & ... Center by the Medical Fitness Association, a non-profit organization ... their full potential. The Cadence Fitness & Health Center ... suburbs and second in the Chicagoland area. ...
    (Date:1/15/2014)... Pharmaceuticals International, Inc. (NYSE: VRX and ... the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ("HSR") with ... indirect wholly-owned subsidiary, Sapphire Subsidiary Corp. ("Purchaser"), for all ... Medical, Inc. (NASDAQ: SLTM ) ("Solta") at ...
    (Date:1/15/2014)...  A novel wearable injector slightly larger than an Oreo cookie ... self-inject prescription drugs in the large doses required to treat ... deficiencies, and genetic disorders.  An emerging biologic ... according to analysts.   Many of these drugs will require a ...
    Breaking Medicine Technology:Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 2Valeant Pharmaceuticals Announces Receipt Of Antitrust Clearance For Its Previously Announced Acquisition Of Solta Medical, Inc. 3Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2
    (Date:4/17/2014)... University of California, San Diego School of Medicine report ... suffered a recent major loss are more likely to ... The study is published in this month,s issue of ... Because compassionate behaviors are associated with better health and ... into ways to improve the outcomes of individuals whose ...
    (Date:4/17/2014)... the April issue of Immunity , Kevin J. ... Research, says it,s time to take a fresh look ... sepsis, which kills millions worldwide every year, including more ... into the bloodstream to fight an injury or infection ... maintaining good health without inflammation, wounds and infections ...
    (Date:4/17/2014)... A Northwestern University synthetic biology team has created ... create programmable therapeutics that could travel the body ... disease. , Engineering cell-based, biological devices that monitor ... in clinical synthetic biology. However, no existing technology ... a patient,s physiological state and respond in a ...
    (Date:4/17/2014)... MAYWOOD, Il. (April 17, 2014) Doctors who ... disease called lymphangioleiomyomatosis (LAM) can face an agonizing ... progression of the disease and help relieve shortness ... lung transplants, and sirolimus can cause potentially fatal ... said pulmonologist Dr. Daniel Dilling, medical director of ...
    (Date:4/17/2014)... YORK, NY (April 16, 2014) The cause of ... a new study proposes that neurons may be mistaken ... immune system, similar to the way autoimmune diseases like ... the body,s cells. The study was published April 16, ... a new, and likely controversial, idea in Parkinson,s disease; ...
    Breaking Medicine News(10 mins):Health News:The ilk of human kindness 2Health News:Feinstein Institute researcher publishes new perspective on sepsis 2Health News:Building 'smart' cell-based therapies 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:Is Parkinson's an autoimmune disease? 2
    ... the nation,s largest independent behavioral health and wellness ... Web site was honored with an eHealthcare ... Conference held November 10-12, 2008 in Orlando, FL. ... Award for Best Site Design for the second ...
    ... first half of 2009.SAN DIEGO, Jan. 6 Amira ... candidate for the treatment and control of inflammatory and ... on target for submission of an IND to the ... the successful completion of Good Laboratory Practices (GLP) toxicity ...
    ... available in French . , Montreal, ... risk delivering aggressive kids according to a new Canada-Netherlands ... . While previous studies have shown that smoking during ... who light up during pregnancy can predispose their offspring ...
    ... MOUNT VERNON, N.Y., Jan. 6 For over ... Prasad has,helped thousands of people including many celebrities ... innovative and highly effective treatment,program. His program combines ... with his trademark Turning Point Treatments to help ...
    ... and Benzoyl Peroxide in a Single Product; Performs ... 6 Galderma Laboratories, L.P. today announced the ... 0.1% / 2.5%, the first and only, once-daily, ... adapalene, and benzoyl peroxide, a well-known antimicrobial with ...
    ... (Nasdaq: COWN ) announced today that Christine Arnold ... care and health care service providers. Ms. Arnold joins Cowen ... from 1999 to 2008. She was previously employed by ... services. Between 2000 and 2008, she has consistently ranked ...
    Cached Medicine News:Health News:ValueOptions(R) Behavioral Health and Wellness Web Site Wins eHealthcare Leadership Award for Best Site Design Second Year in a Row 2Health News:Amira Announces the Successful Completion of GLP Toxicity Studies for a Novel DP2 Antagonist. 2Health News:Smoking during pregnancy fosters aggression in children 2Health News:Stop Smoking in Three Sessions 2Health News:Galderma Announces Availability of Epiduo(TM) Gel, the First and Only Combination Treatment with a Retinoid and Benzoyl Peroxide to Treat Acne 2Health News:Galderma Announces Availability of Epiduo(TM) Gel, the First and Only Combination Treatment with a Retinoid and Benzoyl Peroxide to Treat Acne 3Health News:Galderma Announces Availability of Epiduo(TM) Gel, the First and Only Combination Treatment with a Retinoid and Benzoyl Peroxide to Treat Acne 4Health News:Cowen Adds Health Care Service Analyst to Equity Research Department 2
    ... Stiletto / MVR knife. 1.1 mm (19G) with ... mm (19G) Cannula (5/bx, 1 bx/ca). State-of-the-art manufacturing ... sharp and precise. Sure grip handles have a ... creates a fluid tight incision for self-sealing wounds. ...
    For use in cleaning soft contact lenses. Sensitive Eyes daily cleaner loosens and removes accumulations of film, deposits, and debris from soft contact lenses. Use with heat, chemical, and hydrogen p...
    Complete Blink-N-Clean lens drops cleans and clears lenses in a blink. It is a unique blend of gentle to the eye ingredients that conveniently cleans, clears and keeps lenses feeling comfortable thro...
    ... Renu Multiplus preservative free ... and moisturize your eyes while ... The gentle preservative free formula ... may be sensitive to preservatives ...
    Medicine Products: